文献速递创伤骨科关节外科

假体间股骨骨折与Vancouver C型及Rorabeck II型骨折的手术治疗发生率与结局比较

Incidences and Outcomes of Operatively Treated Interprosthetic Femoral Fractures Compared to Vancouver Type C and Rorabeck Type II Fractures.
PubMed 文献 · J Arthroplasty · 2023-08-18

这项病例对照研究评估了假体间股骨骨折(IPFF,I组)的发生率与结局,并与相似解剖部位的Vancouver C型(II组)和Rorabeck II型(III组)假体周围股骨骨折进行比较。共纳入153例假体周围股骨骨折(I组31例、II组21例、III组108例),I组、II组、III组的年均人群发生率分别为每10万人年0.9、0.7、3.1例。I组10年累积死亡率为50.4%,II组为63.8%,III组为74.9%。

要点

  • IPFF年均发生率为每10万人年0.9例,Vancouver C型为0.7例,Rorabeck II型为3.1例。
  • 153例中25例(16%)发生重大并发症,23例(13%)接受翻修手术。
  • I组10年累积死亡率为50.4%,II组63.8%,III组74.9%。

核心结论

  • IPFF的年发生率几乎翻倍,Vancouver C型发生率保持稳定,Rorabeck II型发生率增加5倍。
  • 大多数重大并发症发生在IPFF组,而Rorabeck II型患者生存率最差。

研究设计与样本

  • 回顾性分析所有既往植入全髋关节置换(THA)和全膝关节置换(TKA)、居住于医院辖区且因假体周围股骨骨折接受手术的患者。
  • 共纳入153例假体周围股骨骨折,分为I组(IPFF,n=31)、II组(Vancouver C型,n=21)和III组(Rorabeck II型,n=108)。
  • 按每10万人汇总假体周围股骨骨折的年发生率,并评估各组并发症、再手术和死亡风险。

主要发现

  • I组年均人群发生率为每10万人年0.9例,II组为0.7例,III组为3.1例。
  • 153例中25例(16%)发生重大并发症,23例(13%)接受翻修手术。
  • I组10年累积死亡率为50.4%,II组为63.8%,III组为74.9%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This case-control study evaluated the incidences and outcomes of interprosthetic femoral fracture (IPFF) (Group I) and performed comparisons with Vancouver type C (Group II) and Rorabeck type II (Group III) periprosthetic femoral fractures (PPFF) occurring at similar anatomic sites. METHODS: A retrospective analysis was performed for all patients who had a previously implanted total hip arthroplasty (THA) and total knee arthroplasty (TKA), who lived in the hospital district and had undergone surgery due to PPFF. A total of 153 PPFFs [Group I (n = 31), Group II (n = 21), and Group III (n = 108)] were included. The annual incidences of PPFFs were summarized per 100,000 individuals. The risks of complications, reoperations, and mortalities were evaluated for all groups. RESULTS: The mean population-based annual incidence was 0.9 per 100,000 person years for Group I, 0.7 per 100,000 person years for Group II, and 3.1 per 100,000 person years for Group III. A total of 25 of 153 (16%) major complications were found and 23 of 153 (13%) cases resulted in a revision surgery. The cumulative incidence of death in Group I was 50.4% at 10 years, in Group II it was 63.8% at 10 years, and in Group III it was 74.9% at 10 years. CONCLUSION: The annual incidence of the IPFF almost doubled while the incidence of Vancouver type C stayed stable and Rorabeck type II incidence increased 5-fold. Most of the major complications occurred in IPFF group, while Rorabeck type II patients had the worst survival.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Miettinen SSA, Sund R, Törmä SV, et al. Incidences and Outcomes of Operatively Treated Interprosthetic Femoral Fractures Compared to Vancouver Type C and Rorabeck Type II Fractures. J Arthroplasty. 2023. PMID: 37597818. doi:10.1016/j.arth.2023.08.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。